Abstract
In their Report “Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production” (6 July, p. [121][1]), W. E. Naugler et al. clearly demonstrated the role of IL-6 in the development of hepatocellular carcinoma (HCC) in mice. In addition, a single estradiol injection
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
